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Abstract 16 
Adversities in pregnancy, including poor diet and stress, are associated with increased risk of 17 
developing both metabolic and mental health disorders later in life, a phenomenon described as 18 
fetal programming or developmental origins of disease. Predominant hypotheses proposed to 19 
explain this relationship suggest that the adversity imposes direct changes to the developing fetus 20 
which are maintained after birth resulting in an increased susceptibility to ill health. However, 21 
during pregnancy the mother, the developing fetus and the placenta are all exposed to the adversity. 22 
The same adversities linked to altered offspring outcome can also result in suboptimal maternal 23 
care which is considered an independent adverse exposure for the offspring. Recent key 24 
experiments in mice reveal the potential of prenatal adversity to drive alterations in maternal care 25 
 2 
through abnormal maternal-pup interactions and via alterations in placental signalling. Together, 26 
these data highlight the critical importance of viewing fetal programming holistically paying 27 
attention to the intimate, bidirectional and reiterative relationship between mothers and their 28 
offspring. 29 
 30 
1 Introduction 31 
One of the most common adversities to blight pregnancy is overnutrition, which is estimated to 32 
impact one third of all pregnancies in developed countries. Further, there is an increasing burden 33 
to developing countries[1]. Obesity in pregnancy is specifically associated with higher risk of 34 
pregnancy complications and poorer outcomes for children. These include the increased risk of 35 
neurologic disorders including attention deficit/hyperactivity disorder, autism and schizophrenia as 36 
well as metabolic syndrome – findings that have, at least in principle, been reproduced in a number 37 
of animal models [2]. The reported association between obesity and other prenatal adversities with 38 
later life illnesses has led to suggestions that the exposure induces direct changes to the fetus which 39 
persist into adulthood increasing susceptibility to disease – a relationship which is often referred to 40 
as fetal programming [3] or developmental origins of disease [4]. However, in humans exposures 41 
rarely occur in isolation nor are they limited to pregnancy, and there are different patterns and long-42 
term consequences of fetal adversities depending on their timing, nature and magnitude. 43 
Considerable progress in our understanding of the mechanisms underpinning the fetal 44 
programming phenomenon has been made using animal models but until recently little attention 45 
has been paid to the impact of prenatal adversities on the mother’s health and behaviour, and how 46 
the combination of prenatal adversity and suboptimal maternal care could contribute to offspring 47 
outcomes [5]. This is important because variations in maternal care in rodents, independent of 48 
prenatal exposures,  have been linked to altered offspring behaviour and persistent changes in the 49 
offspring brain [6]. High fat diet (HFD) [7-9], low protein diet (LPD) [10], chronic, psychological stress [11], 50 
 3 
physical restraint [12], chronic corticosterone administration [13] and vitamin D deficiency [14] in 51 
pregnancy are just some of the stressors that have been reported to induce changes in maternal 52 
behaviour in animal models. There is very little data on the consequences specifically of high fat diet 53 
in a human pregnancy on maternal care but maternal obesity is a well known risk factor for maternal 54 
depression and anxiety [15] and there are studies that link maternal obesity to lower quality maternal 55 
attachment [16] and maternal parenting stress [17]. Consequently, adversities in the prenatal period 56 
may contribute to altered outcomes either directly by impacting the fetus or indirectly by altering 57 
maternal care giving, or potentially by both routes. This imposes considerable complexities in the 58 
interpretation of studies characterising the causes and consequences of early life adversity.  Recent 59 
studies have begun to address gaps in our knowledge and, through careful experimental design, 60 
demonstrate that both prenatal and postnatal communication between offspring and mother has 61 
the potential to influence postpartum maternal care potentially contributing to longer term 62 
outcomes.  63 
 64 
2 High fat diet influences maternal behaviour through changes to offspring 65 
In a recent study published in Proceeding of the Royal Society B, Baptissart and colleagues employed 66 
a high fat diet (HFD) intervention with cross fostering to dissect apart the contribution of the 67 
stressor of obesity and HFD in pregnancy to alterations in maternal behaviour [18]. HFD has 68 
previously been reported to result in alterations in maternal care  but in all but one of these studies, 69 
dams continued on the dietary alteration while their behaviour was being assessed (Table 1). In this 70 
study, female C57BL/6 mice were fed either a control diet (10% calories from fat) or a HFD (45% 71 
calories from fat) from 3 weeks of age to 9 weeks of age. Prior to mating, dams fed on the HFD 72 
gained more weight and were less glucose tolerant than dams fed the control diet.  After mating to 73 
males maintained on a control diet, pregnant dams remained on their respective diets throughout 74 
pregnancy and while mothering their pups. At birth, four experimental groups were generated: 1) 75 
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dams fed a control diet caring for control diet-exposed offspring (CT:ct); 2) dams fed a HFD caring 76 
for HFD-exposed offspring (HF:hf); 3) dams fed the control diet caring for HFD-exposed offspring 77 
(CT:hf); and 4) dams fed a HFD caring for control diet-exposed offspring (HF:ct) (Figure 1a). In all 78 
cases, pups were either fostered within groups or across groups to control for the disruption of this 79 
event, and pup sex was balanced. HF:hf dams spent less time interacting with their pups and nesting, 80 
and more time on non-interactive behaviours (exploration, wall-rearing) than CT:cf dams, 81 
essentially as previously reported [7, 8]. However, dams nursing mis-matched pups (CT:hf and HF:ct)  82 
did not clearly align with either matched pairing. This demonstrated that the HFD is not purely acting 83 
as a stressor on the dam altering her behaviour. Instead, both the prenatal and postnatal 84 
environment contribute to the altered maternal behaviour. Further analysis in a generalised linear 85 
model identified in utero exposure of the fetus as the strongest predictor of the postnatal maternal 86 
behaviour i.e. pups exposed in utero to the HFD appeared to be influencing the behaviour of dams 87 
not exposed to the diet. This remarkable study demonstrates that an adversity experienced by the 88 
fetus in utero has the potential to alter the mother’s behaviour postpartum. 89 
 90 
3 Offspring communication regulated by imprinting influence maternal behaviour  91 
The newborn is known to elicit maternal care through many different interactions,  any one of which 92 
could be impacted during fetal development. Newborns influence maternal care-giving behaviour 93 
through suckling [19], through calls in the form of ultrasonic vocalisations (USVs) [20] and, potentially, 94 
through body temperature changes, as recently reviewed [21]. Although maternal HFD has not been 95 
reported to impact suckling behaviour [22], HFD-exposed offspring can exhibit alterations in USVs [23]. 96 
Pup USVs normally increase in intensity and frequency during separations from the mothers, hence 97 
the term “whistles of loneliness”   [24]. These communications from the pups are known to stimulate 98 
a number of maternal behaviours including nest building, pup retrieval and nursing [20]. Seven day 99 
old pups exposed gestationally to a HFD (60% calories from fat) reportedly vocalise less than non-100 
 5 
exposed controls (13.5% calories from fat) when isolated from their mothers [23]. Therefore, HFD in 101 
pregnancy could alter maternal behaviour by impacting the offspring’s ability to communicate 102 
postnatally. While Baptissart and colleagues did not measure USVs in their study and findings from 103 
different HFD studies vary (Table 1), nonetheless the observation that prenatally exposed pups can 104 
influence a foster mother’s behaviour postnatally means that studies in animal models linking 105 
prenatal adversity to later life health must be carefully interpreted. Adversities in pregnancy may 106 
disrupt maternal care indirectly by changing the way in which the offspring  communicate with their 107 
mothers after they are born (Figure 2). 108 
 109 
We recently reported reduced USVs in  pups with loss-of-function of Paternally expressed gene 3 110 
(Peg3) [25]. Peg3 null pups born to wild dams make significantly less USVs when separated from their 111 
mothers than wild type pups (Figure 1b). Consistent with the importance of USVs in pup retrieval 112 
[26], wild type dams who carried and cared for these low vocalising pups were significantly slower to 113 
sniff and then to retrieve their pups. We observed no changes in a nest building behaviour nor in 114 
the dams’ direct interactions with their pup during the nest building task. There was, however, a 115 
marked difference in maternal anxiety between the dams carrying and caring for wild type pups and 116 
those that carried and cared for Peg3 null pups with dams exposed to the Peg3 null pups displaying 117 
higher levels of anxiety in the elevated zero maze test. Loss of Peg3 expression has a significant 118 
negative impact on placental development and fetal growth [27, 28]. Importantly, Peg3 mutant mice 119 
display both metabolic [29] and behavioural disorders as adults [27] [30]. The reason this study is 120 
relevant to research into fetal programming is because Peg3 belongs to the remarkable family of 121 
imprinted genes that are expressed exclusively or predominantly from one parental allele as a 122 
consequence of epigenetic events initiated in the parental germline and consolidated after 123 
fertilisation [31]. Changes in epigenetic gene regulation induced by the prenatal adversity have been 124 
suggested as a mechanism underpinning the fetal programming phenomenon, recently reviewed 125 
 6 
[32]. Epigenetic marks, which are by definition inherited through the cell cycle, play a key role in 126 
maintaining a cellular memory of gene transcription patterns. Therefore, environmental exposures 127 
that alter epigenetic marks can, in theory, be “remembered” by the organism even after the 128 
exposure stops.  129 
 130 
4 Prenatal adversities alter the expression of imprinted genes 131 
A number of interventions in pregnancy have been linked to the altered expression of imprinted 132 
genes in the offspring (Table 2). As an example, we recently showed that a low protein diet 133 
restricted to pregnancy results in loss of paternal silencing of the imprinted gene Cdkn1c in the 134 
offspring maintained into adulthood [33]. This formally demonstrates that adversity in pregnancy can 135 
influence the epigenetic processes that maintain allelic gene expression in the developing fetus. 136 
High fat diet, in combination with prenatal obesity or just during pregnancy, has not been shown to 137 
impact expression of Peg3.  Further work is therefore required to demonstrate Peg3 responds 138 
epigenetically to prenatal adversity. Moreover, loss of expression is a considerable insult to 139 
development and it will need to be shown that more modest changes in gene expression have a 140 
phenotypic consequence that could impact another individual’s behaviour. 141 
 142 
5 Placental imprinting modulates maternal behaviour 143 
Interpreting studies on the interaction between prenatal adversities and later life outcomes is 144 
further complicated by the potential of placental endocrine dysfunction to alter outcomes for 145 
mother and offspring. The placenta is a fetally-derived organ predominantly recognised for its role 146 
as a sophisticated transportation system bringing nutrients to the fetus and removing waste. Less 147 
well recognised is the function of the placenta as the signalling coordinator of pregnancy. The 148 
placenta manufactures vast quantities of hormones that act on the mother to establish and 149 
maintain the adaptations necessary for pregnancy [34] and promote fetal brain development [35]. 150 
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Hormones produced by the placenta include placental lactogen-like hormones (Prls) some of which 151 
are known to bind and activate the prolactin receptor [36]. This receptor is required for the 152 
appropriate induction of maternal care in mice [37] with a key site of action being the medial preoptic 153 
area of the hypothalamus [38]. Infusion of placental lactogen directly into this area of the  brain 154 
induces maternal care in the non-pregnant rodent [39]. These indirect infusion experiments highlight 155 
the potential function of the placenta in the programming of maternal care. We recently tested this 156 
theory in a novel mouse model in which we were able to manipulate the size of the placental 157 
endocrine compartment by genetically altering the expression of the imprinted gene Phlda2. Phlda2 158 
negatively regulates the major endocrine lineage of the mouse placenta [40]. We exposed wild type 159 
female mice to fetuses with different doses of Phlda2, and thus to different doses of placental 160 
hormones. As the dose of placental hormones increased, we observed increased maternal nurturing 161 
and pups grooming [41]. This experiment formally demonstrates that imprinted genes expressed in 162 
the placenta, and regulated by epigenetic marks, can influence the behaviour of mothers. This opens 163 
the possibility that prenatal adversities in pregnancy could influence maternal behaviour via 164 
alterations in the placenta mediated by imprinted genes (Figure 2).  165 
 166 
6 Potential for prenatal adversity to alter placenta signalling 167 
A number of studies report changes in placental hormones and/or placental endocrine lineages 168 
after exposures of pregnant females to a variety of stressors (Table 3). One study examining 169 
overnutrition in pregnancy specifically assayed the expression of placental hormones and reported 170 
a significant decrease in the expression of two hormones [42]. In another study, changes in fat 171 
content of the maternal diet altered the expression of a number of hormones in the placenta in a 172 
sexually dimorphic manner [43]. Evidence that maternal stressors impact the expression of imprinted 173 
genes that regulate development of placental endocrine lineages is less well established. A focused 174 
study on the consequences of an obesogenic diet on the placental expression of imprinted genes 175 
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reported increased expression of several imprinted genes including Igf2 and a non-significant 176 
increase in expression of Phlda2 [44]. In rats, LPD resulted in decreased expression of placental Ascl2 177 
[45]. As well as diet, the infection status of the dams appears to be important for placental imprinted 178 
gene expression. Challenging pregnant dams with Campylobacter rectus, a periodontal pathogen 179 
associated with adverse pregnancy outcomes, resulted in decreased placental expression of several 180 
imprinted genes including Ascl2 and Igf2 [46]. Together, these data support an interaction between 181 
maternal stressors and alterations in the expression of imprinted genes. However, few studies have 182 
examined allelic expression changes in the placenta and it is not clear whether these changes in 183 
expression occur as a result of changes in imprinting, changes in the expression of the normally 184 
active allele or changes in cellular composition, which must be addressed.  185 
 186 
7 Conclusions and Outlook 187 
In conclusion, there is considerable experimental evidence that the environment mothers 188 
experience in pregnancy can alter her behaviour towards her offspring. There is emerging evidence 189 
that adverse exposures may act not directly on the mother but indirectly via her developing fetus 190 
and associated placenta. Together, these data highlight the critical importance of viewing fetal 191 
programming holistically paying attention to the intimate, bidirectional and reiterative relationship 192 
between mothers and offspring (Figure 2).  193 
 9 
Figure legends 194 
Figure 1. Neonatal and placental influences on maternal behaviour 195 
Dietary influence on maternal behaviour via the exposed neonate. Obese wild type dams exposed 196 
to high fat diet (HFD) in pregnancy give birth to pups that can influence a normal weight, non-HFD 197 
exposed dam’s behaviour. Arrows indicate fostering of pups to generate matched and mis-matched 198 
groups. 199 
Programming of maternal care by placental imprinting. Wild type dams exposed to fetuses with 200 
different gene doses of the maternally expressed Phlda2 gene (doses given in top row of table) and 201 
consequently different doses of placental hormones (doses given in bottom row of table) show 202 
alterations in pup focused behaviours consistent with the role of placental hormones in inducing 203 
maternal care. Enhanced behaviour is maintained even when “programmed” dams are given pups 204 
from another dam. 205 
 206 
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Figure 2. Prenatal adversity and the intimate, bidirectional and reiterative relationship between 207 
mother and offspring. 208 
Prenatal adversities expose the mother, the developing fetus and the placenta. Alterations to the 209 
fetus have the potential to change the way the child interacts with their mother after birth (solid 210 
arrow), resulting in suboptimal maternal care. Alterations to the placenta have the potential to 211 
misprogram maternal behaviour (dotted arrow) also resulting in suboptimal maternal care. These 212 
misaligned reiterative interactions between mother and child (solid double headed arrow) further 213 
contribute to poor outcomes for children later in life. 214 
 215 
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Tables 216 
 217 
Table 1. High fat diet protocols associated with alterations in maternal behaviour 218 
Only rodent studies focused on high fat diet protocols and maternal behaviour are reported 219 
Species Diet Duration of 
HFD 
Response to HFD  Reference 
Sprague-
Dawley 
rats 
45% v. 25% 
v. 5% fat by 
weight 
One week 
premating for 
duration 
Decreased and delayed non-postural 
nursing 
Increased postural nursing 
Decreased total nursing 
Increased pup grooming 
Increased self grooming 
More time with litter 
[47] 
Sprague-
Dawley 
rats 
60% v. 17% 
calories 
from fat 
From day 2 of 
gestation for 
duration 
Dark phase/week one: 
Increased arch back nursing  
Increased total nursing 
Decreased resting 
[9] 
Wistar 
rats 
45% v. 18% 
calories 
from fat 
From day 1 of  
gestation for 
duration 
P3 to P8 
Decreased licking and grooming of pups 
[7] 
C57BL/6 
mice 
58% v. 
10.5% 
calories 
from fat 
10 weeks 
premating to 
E15.5 
Increased frequency of cannibalistic 
episodes 
[48] 
 12 
C57BL/6 
mice 
45% v. 10% 
calories 
from fat 
6 weeks 
premating for 
duration 
Decreased pup interactions/increased 
exploration 
[18] 
 220 
Table 2. Prenatal adversities resulting the altered expression of imprinted genes. 221 
Only studies explicitly reporting altered expression of imprinted genes are reported. For mouse 222 
studies the first day of visible plug is referred to as embryonic day (E) 0.5. For rat studies, first day 223 
of observable sperm can be referred to as gestational day (GD) 1. LPD = low protein diet; HFD = high 224 
fat diet; QPCR = quantitative real time polymerase chain reaction. 225 
 226 
Species Stressor Duration Findings Reference 
ICR mice 50% food 
restriction 
E12.5 to E16.5 QPCR: decreased brain Cdkn1c and 
Snrpn; increased liver H19, Grb10, 
Peg3 (male), Igf2r (female) and 
Zac1 (female) at E16.5 
[49] 
C57BL/6 
mice 
 
LPD (8% 
calories from 
protein) v. 
Control (20%) 
E0.5 to term QPCR at P21: decreased liver Gnas  [50]  
Wistar rats Intraperitoneal 
dexamethasone 
at GD15 
GD15-GD20 
 
QPCR at GD20: increased liver Igf2, 
Cdkn1c, Grb10 and H19; 
decreased placental Igf2 
[51]  
 13 
Cdkn1c-
FLucLacZ 
129S2/SvHsd 
LPD (8.1% 
calories from 
protein) v 
control (18.3%) 
E0.5 to E18.5 QPCR and Imaging: reactivation of 
paternal Cdkn1c allele 
[33] 
ICR mice 50% food 
restriction 
E12.5 to E16.5 QPCR at E16.5: Increased placental 
Peg3 
[49] 
C57BL/6 
mice 
 
HFHS (30% 
calories from 
fat, 36% sugar) 
v control diet 
(11% fat, 7% 
sugar) 
E0.5 to E15.5 
 
QPCR at E15.5: increased placental 
Igf2 (non-significant increase in 
Phlda2 and Cdkn1c) 
 
[44]  
C57BL/6 
mice 
Cafeteria (58% 
calories from 
fat) v. control 
(10.5%) 
12 weeks 
premating to 
E14.5 
QPCR: increased placental Igf2 
(male only). 
[52]  
Sprague-
Dawley rats 
 
HFD (60% 
calories from 
fat) v. control 
(13.5%)   
GD2 to GD21 QPCR: increased placental Igf2 
(female only). 
[53] 
Sprague-
Dawley rats 
 
LPD (4.6% 
calories from 
protein) v. 
Control (19%) 
GD1 to GD14 or 
GD18 
QPCR: decreased Ascl2 day 18.  [45] 
 14 
CD1 mice LPD (6% 
calories from 
protein) v. 
control (22%) 
E4.5 to E17.5 with 
or without oral 
gavage of 
Heligmosomoides 
bakeri worms 
Microarray: LPD only - increased 
placental Igf2.  
[54] 
BALB/c mice 
 
Intra-chamber 
injection of live 
Campylobacter 
rectus strain 
314 at E7.5 
E7.5 to E16.5 Microarray: decreased placental 
Ascl2, Igf2, Cdkn1c, Peg3 
 
[46] 
 227 
 228 
Table 3. Prenatal adversities associated with  alterations consistent with placental endocrine 229 
dysfunction.  230 
Only changes in members of the placental lactogen-like gene family (Prls) or placental endocrine 231 
lineages are reported. Where publications state “placental prolactin” in late gestation, they likely 232 
refer to placental lactogens. In mice, day of visible plug is embryonic (E) day 0.5 and length of 233 
gestation is 19-20 days depending on strain. In rats, day of sperm cell detection in female is day 1 234 
and length of gestation is 21-24 days depending on strain 235 
 236 
Species Stressor Duration Findings Reference 
Dietary Stressors 
C57BL/6 
mice 
HFHS (30% 
calories from fat, 
From E0.5 to E15.5 
 
QPCR: decreased placental 
Prl2b1 and Prl7b1  
[42]  
 15 
 36% sugar) v 
control diet (11% 
calories from fat, 
7% sugar) 
NIH Swiss 
mice 
 
LFD (10% calories 
from fat) versus 
“control” (26% 
calories from fat) 
v. HFD (54% 
calories from fat) 
From 30-35 weeks 
premating to 
E12.5 
Microarray: changes in 
male/female ratio of Prl2c3, 
Prl3b1, Prl3d2, Prl5a1 and 
Prl7c1.  
[43]  
 
Dorset 
Horn×Mule 
 sheep 
Moderate v. high 
levels of nutrition 
After transfer of 
day 4 embryos 
(Border 
Leicester/Scottish 
Blackface x Dorset 
Horn) until day 
100 of gestation 
Radioimmunoassay: low 
maternal serum placental 
lactogen  
 
[55]  
Swiss 
Webster 
(ND4) mice 
 
50% food 
restriction 
From E1.5 to E11.5 Histology: reduced junctional 
zone 
Microarray: decreased placental 
Prl8a8.  
[56]  
Fischer 344 
rat 
LPD (5% calories 
from protein) v. 
20% alcohol in 
From day 6 to day 
20  
Radio-receptor assay:  [57] 
 16 
water v. control 
(18% calories 
from protein) 
decreased maternal serum and 
placental levels of “prolactin” 
(both LPD and alcohol) 
C57BL/6 
mice 
 
LPD (6% calories 
from protein) v. 
Control (20%) 
Two weeks 
premating to 
E10.5, E17.5 or 
E18.5 
Histology: reduced junctional 
zone 
QPCR: decreased Prl3a1 at 
E18.5 (non-signficant decrease 
in Prl5a1 and Prl8a8) 
 
Fischer 344 
rat 
LPD (5% calories 
from protein) v. 
control (20% 
calories from 
protein) 
From day 6 to day 
20 
Radio-immuno assay: decreased 
maternal serum levels of rat 
“prolactin” 
[58]  
Sprague-
Dawley rats 
LPD (6% calories 
from protein) pair 
matched with 
control (20% 
calories from 
protein) 
From day 6 to day 
19 
Northern: Decreased placental 
Prl6a1;   
Western: Reduced Prl6a1 
secretion from explant cultures. 
[59] 
Sprague-
Dawley rats 
 
LPD (4.6% 
calories from 
protein) v. control 
(19% calories 
from protein) 
From conception 
to day 14 or day 18 
QPCR: decreased placental 
Prl5a1 and Prl2c1 day 14 and 18 
[45] 
 17 
CD1 mice LPD (6% calories 
from protein) v. 
control (22% 
calories from 
protein) with or 
without oral 
gavage of 
Heligmosomoides 
bakeri worms 
From E4.5 to E17.5  Microarray: LPD only - 
decreased placental “prolactin”,  
[54] 
Other maternal stressors 
Holtzman 
rats  
 
Continuous 
infusion of 
dexamethasone 
From day 13 to day 
20 
 
Mini-array analyses and 
Northern: decreased Prl8a8, 
Prl3b1, Prl6a1 and Prl3d4;  
In situ hybridisation: 
mislocalisation of 
spongiotrophoblast into 
labrynth 
 
[60] 
Suffolk 
sheep 
Heat stress (40oC 
for 9 hours per 
day then 30oC for 
15 hours/day; 
40% humidity) v. 
thermoneutral 
From day 64 to day 
136-141 
Radioimmunoassay: reduced 
maternal serum placental 
lactogen (by >60%). 
[61] 
 18 
(18-20oC; 30% 
humidity). 
Fisher rats Chromium (IV) in 
tap water 
From day 7 to Day 
19 
Northern blot: decreased 
placental Prl3d1 and Prl3b1; 
Prl4a1, Prl8a2. 
Radioimmunoassay: decreased 
maternal serum Prl3d1 and 
Prl3b1; 
Histology: reduced 
“spongiotrophoblast”  
[62]  
CD1 mice Perfluorooctanoic 
acid by gavage 
From E10.5 to 
E15.5 
 
Histology: Decrease in parietal 
trophoblast giant cells, glycogen 
cells and sinusoidal trophoblast 
giant cells; 
Northern: decreased placental 
Prl3b1, Prl7a1 and Prl7a2. 
[63] 
Sprague-
Dawley rats 
Triclosan by 
gavage 
From day 6 to day 
20 
Radio-immunoassay: decreased 
maternal serum “prolactin” 
[64] 
CD1 mice Reduced utero-
placental 
perfusion 
pressure 
From E12.5 to 
E16.5-E18.5 
 
In situ hybridisation: reduced 
area of junctional zone. 
[65] 
 237 
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